Showing results 7 to 11 of 11
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Patients’ and clinicians’ expectations on integrative medicine Services for Diabetes: a focus group study Journal:BMC Complementary Medicine and Therapies | 2020 | ||
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis Journal:Frontiers in Pharmacology | 2022 | ||
2016 | |||
2019 | |||
The PAR-1 antagonist Vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis Journal:Clinical Science | 2020 |